USANA HEALTH SCIENCES INC
Financial highlights
| Metric | FY January 3, 2026 | FY December 28, 2024 | FY December 30, 2023 | FY December 31, 2022 | FY January 1, 2022 |
|---|---|---|---|---|---|
| Revenue | $925.3M | $854.5M | $921.0M | $998.6M | $1.2B |
| Gross profit | $724.4M | $693.3M | $744.3M | $804.7M | $968.6M |
| Operating income | $37.4M | $66.3M | $93.1M | $107.6M | $170.2M |
| Operating expenses | $687.0M | $627.0M | $651.2M | $697.1M | $798.4M |
| Cost of revenue | $200.9M | $161.2M | $176.7M | $193.9M | $217.9M |
| Cash from operations | $22.3M | $61.0M | $70.6M | $103.9M | $121.2M |
| Capital expenditure | $13.8M | $10.1M | $14.5M | $10.4M | $12.8M |
| Free cash flow | $8.5M | $50.9M | $56.1M | $93.5M | $108.5M |
| Share repurchases | $27.5M | $9.4M | $11.6M | $25.4M | $177.8M |
| Impairments | $6.5M | $0 | $0 | $0 | $0 |
| Total assets | $742.9M | $748.2M | $632.8M | $596.5M | $577.7M |
| Total liabilities | $156.6M | $161.9M | $135.6M | — | — |
Shares outstanding 18.5M · Free float 50.8%
Annual filing data through FY ended January 3, 2026; float as of July 11, 2026.